Prescribing of weight-loss medications
At OVA, we believe that health and wellbeing should be accessible, convenient, and personal. That belief has shaped two of our telehealth businesses, OVA for female healthcare needs respectively.
To ensure a modern experience that enables patients to access the care they need, our services have been built to mirror the one-to-one in-person doctor and patient consultation process in a video setting. Our telehealth services are available in Singapore, Malaysia, and the Philippines, led by experienced doctors local to each market.
When patients consult our doctors for assessment of their healthcare needs related to being overweight or obese, a combination of lifestyle and medical advice is provided in-line with local and international clinical guidelines.
OVA doctors deem over 40% of people who seek their advice in relation to being overweight or obese as unsuitable for prescription medicines that can help eligible patients to lose weight. For those who are deemed eligible, per local and international clinical guidelines, OVA doctors might prescribe one of the medications that we provide to support weight management.
The weight loss medications a doctor working as part of OVA's telehealth services can consider prescribing, as part of a holistic plan including diet and exercise, include:
- Saxenda, an injectable treatment containing glucagon-like peptide-1 (GLP-1), a natural hormone that helps to regulate blood glucose levels;
- Xenical, a prescription strength ‘lipase inhibitor’, taken orally in capsule form, that prevents the absorption of dietary fats;
- Duromine, a prescription capsule medication which suppresses appetite.
The above medications are approved by the relevant regulatory authorities, specifically for weight management, in the markets OVA operates within.
OVA does not stock GLP-1 medications for diabetes management that are sometimes prescribed ‘off-label’ for weight loss.
Prescription weight-loss medicines can play a critical role in tackling the challenge of obesity and getting people back to sustainable good health. They are serious medicines that must only be used responsibly by eligible patients under medical supervision.